The administration of ACEI/ARB (angiotensin‐converting enzyme inhibitors/Angiotension II
receptor blockers) in COVID‐19 (coronavirus disease 2019) patients with hypertension …

The pandemic of coronavirus disease 2019 (COVID-19) is a global health emergency that
poses a significant threat to world people's health. This outbreak causes major challenges to …

HMG-CoA reductase inhibitors improve endothelial function and exert antiproliferative
effects on vascular smooth muscle cells of systemic vessels. This study was aimed to assess …

The article describes the possible pathophysiological origin of COVID-19 and the crucial
role of renin-angiotensin system (RAS), providing several “converging” evidence in support …

DOI: 10.1161/HYPERTENSIONAHA. 120.16261 e42 Hypertension December 2020 found
for AngII receptor blockers (odds ratio, 2.3 [95% CI, 0.3–21.4]; P= 0.453). No relevant effects …

Deficiency of tetrahydrobiopterin (BH4) in the vascular tissue contributes to endothelial
dysfunction through reduced eNOS activity and increased superoxide anion (O2−) …

From the beginning of the pandemic hypertension appeared as one of the most common
comorbidities in patients hospitalised with a Covid-19 infection. Hypertension, diabetes …

Objective: The present study was performed to examine whether the blood pressure (BP)-
lowering effects of soluble epoxide hydrolase (sEH) inhibition in two-kidney, one-clip (2K1C) …

The present study was designed to evaluate the possible in vivo protective effects of
sesamin on hypertension and endothelial function in two-kidney, one-clip renovascular …

Background: The blood pressure lowering effect of sesamin has been demonstrated to be
associated with the increase in vascular nitric oxide (NO) biological activity by our previous …